Amyloid-β oligomers impair fear conditioned memory in a calcineurin-dependent fashion in mice

Kelly Dineley, Rakez Kayed, Volker Neugebauer, Yu Fu, Wenru Zhang, Lindsay C. Reese, Giulio Taglialatela

Research output: Contribution to journalArticle

67 Citations (Scopus)

Abstract

Soluble oligomeric aggregates of the amyloid-β (Aβ) peptide are believed to be the most neurotoxic Aβ species affecting the brain in Alzheimer disease (AD), a terminal neurodegenerative disorder involving severe cognitive decline underscored by initial synaptic dysfunction and later extensive neuronal death in the CNS. Recent evidence indicates that Aβ oligomers are recruited at the synapse, oppose expression of long-term potentiation (LTP), perturb intracellular calcium balance, disrupt dendritic spines, and induce memory deficits. However, the molecular mechanisms behind these outcomes are only partially understood; achieving such insight is necessary for the comprehension of Aβ-mediated neuronal dysfunction. We have investigated the role of the phosphatase calcineurin (CaN) in these pathological processes of AD. CaN is especially abundant in the CNS, where it is involved in synaptic activity, LTP, and memory function. Here, we describe how oligomeric Aβ treatment causes memory deficits and depresses LTP expression in a CaN-dependent fashion. Mice given a single intracerebroventricular injection of Aβ oligomers exhibited increased CaN activity and decreased pCREB, a transcription factor involved in proper synaptic function, accompanied by decreased memory in a fear conditioning task. These effects were reversed by treatment with the CaN inhibitor FK506. We further found that expression of hippocampal LTP in acutely cultured rodent brain slices was opposed by Aβ oligomers and that this effect was also reversed by FK506. Collectively, these results indicate that CaN activation may play a central role in mediating synaptic and memory disruption induced by acute oligomeric Aβ treatment in mice.

Original languageEnglish (US)
Pages (from-to)2923-2932
Number of pages10
JournalJournal of Neuroscience Research
Volume88
Issue number13
DOIs
StatePublished - Oct 2010

Fingerprint

Long-Term Potentiation
Calcineurin
Amyloid
Fear
Memory Disorders
Tacrolimus
Alzheimer Disease
Dendritic Spines
Long-Term Memory
Brain
Pathologic Processes
Neurodegenerative Diseases
Synapses
Rodentia
Transcription Factors
Therapeutics
Calcium
Peptides
Injections

Keywords

  • Alzheimer disease
  • LTP
  • pCREB
  • PP-2B

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience

Cite this

Amyloid-β oligomers impair fear conditioned memory in a calcineurin-dependent fashion in mice. / Dineley, Kelly; Kayed, Rakez; Neugebauer, Volker; Fu, Yu; Zhang, Wenru; Reese, Lindsay C.; Taglialatela, Giulio.

In: Journal of Neuroscience Research, Vol. 88, No. 13, 10.2010, p. 2923-2932.

Research output: Contribution to journalArticle

@article{085677b46d59481b899eb6b534c2f19e,
title = "Amyloid-β oligomers impair fear conditioned memory in a calcineurin-dependent fashion in mice",
abstract = "Soluble oligomeric aggregates of the amyloid-β (Aβ) peptide are believed to be the most neurotoxic Aβ species affecting the brain in Alzheimer disease (AD), a terminal neurodegenerative disorder involving severe cognitive decline underscored by initial synaptic dysfunction and later extensive neuronal death in the CNS. Recent evidence indicates that Aβ oligomers are recruited at the synapse, oppose expression of long-term potentiation (LTP), perturb intracellular calcium balance, disrupt dendritic spines, and induce memory deficits. However, the molecular mechanisms behind these outcomes are only partially understood; achieving such insight is necessary for the comprehension of Aβ-mediated neuronal dysfunction. We have investigated the role of the phosphatase calcineurin (CaN) in these pathological processes of AD. CaN is especially abundant in the CNS, where it is involved in synaptic activity, LTP, and memory function. Here, we describe how oligomeric Aβ treatment causes memory deficits and depresses LTP expression in a CaN-dependent fashion. Mice given a single intracerebroventricular injection of Aβ oligomers exhibited increased CaN activity and decreased pCREB, a transcription factor involved in proper synaptic function, accompanied by decreased memory in a fear conditioning task. These effects were reversed by treatment with the CaN inhibitor FK506. We further found that expression of hippocampal LTP in acutely cultured rodent brain slices was opposed by Aβ oligomers and that this effect was also reversed by FK506. Collectively, these results indicate that CaN activation may play a central role in mediating synaptic and memory disruption induced by acute oligomeric Aβ treatment in mice.",
keywords = "Alzheimer disease, LTP, pCREB, PP-2B",
author = "Kelly Dineley and Rakez Kayed and Volker Neugebauer and Yu Fu and Wenru Zhang and Reese, {Lindsay C.} and Giulio Taglialatela",
year = "2010",
month = "10",
doi = "10.1002/jnr.22445",
language = "English (US)",
volume = "88",
pages = "2923--2932",
journal = "Journal of Neuroscience Research",
issn = "0360-4012",
publisher = "Wiley-Liss Inc.",
number = "13",

}

TY - JOUR

T1 - Amyloid-β oligomers impair fear conditioned memory in a calcineurin-dependent fashion in mice

AU - Dineley, Kelly

AU - Kayed, Rakez

AU - Neugebauer, Volker

AU - Fu, Yu

AU - Zhang, Wenru

AU - Reese, Lindsay C.

AU - Taglialatela, Giulio

PY - 2010/10

Y1 - 2010/10

N2 - Soluble oligomeric aggregates of the amyloid-β (Aβ) peptide are believed to be the most neurotoxic Aβ species affecting the brain in Alzheimer disease (AD), a terminal neurodegenerative disorder involving severe cognitive decline underscored by initial synaptic dysfunction and later extensive neuronal death in the CNS. Recent evidence indicates that Aβ oligomers are recruited at the synapse, oppose expression of long-term potentiation (LTP), perturb intracellular calcium balance, disrupt dendritic spines, and induce memory deficits. However, the molecular mechanisms behind these outcomes are only partially understood; achieving such insight is necessary for the comprehension of Aβ-mediated neuronal dysfunction. We have investigated the role of the phosphatase calcineurin (CaN) in these pathological processes of AD. CaN is especially abundant in the CNS, where it is involved in synaptic activity, LTP, and memory function. Here, we describe how oligomeric Aβ treatment causes memory deficits and depresses LTP expression in a CaN-dependent fashion. Mice given a single intracerebroventricular injection of Aβ oligomers exhibited increased CaN activity and decreased pCREB, a transcription factor involved in proper synaptic function, accompanied by decreased memory in a fear conditioning task. These effects were reversed by treatment with the CaN inhibitor FK506. We further found that expression of hippocampal LTP in acutely cultured rodent brain slices was opposed by Aβ oligomers and that this effect was also reversed by FK506. Collectively, these results indicate that CaN activation may play a central role in mediating synaptic and memory disruption induced by acute oligomeric Aβ treatment in mice.

AB - Soluble oligomeric aggregates of the amyloid-β (Aβ) peptide are believed to be the most neurotoxic Aβ species affecting the brain in Alzheimer disease (AD), a terminal neurodegenerative disorder involving severe cognitive decline underscored by initial synaptic dysfunction and later extensive neuronal death in the CNS. Recent evidence indicates that Aβ oligomers are recruited at the synapse, oppose expression of long-term potentiation (LTP), perturb intracellular calcium balance, disrupt dendritic spines, and induce memory deficits. However, the molecular mechanisms behind these outcomes are only partially understood; achieving such insight is necessary for the comprehension of Aβ-mediated neuronal dysfunction. We have investigated the role of the phosphatase calcineurin (CaN) in these pathological processes of AD. CaN is especially abundant in the CNS, where it is involved in synaptic activity, LTP, and memory function. Here, we describe how oligomeric Aβ treatment causes memory deficits and depresses LTP expression in a CaN-dependent fashion. Mice given a single intracerebroventricular injection of Aβ oligomers exhibited increased CaN activity and decreased pCREB, a transcription factor involved in proper synaptic function, accompanied by decreased memory in a fear conditioning task. These effects were reversed by treatment with the CaN inhibitor FK506. We further found that expression of hippocampal LTP in acutely cultured rodent brain slices was opposed by Aβ oligomers and that this effect was also reversed by FK506. Collectively, these results indicate that CaN activation may play a central role in mediating synaptic and memory disruption induced by acute oligomeric Aβ treatment in mice.

KW - Alzheimer disease

KW - LTP

KW - pCREB

KW - PP-2B

UR - http://www.scopus.com/inward/record.url?scp=77957233071&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957233071&partnerID=8YFLogxK

U2 - 10.1002/jnr.22445

DO - 10.1002/jnr.22445

M3 - Article

VL - 88

SP - 2923

EP - 2932

JO - Journal of Neuroscience Research

JF - Journal of Neuroscience Research

SN - 0360-4012

IS - 13

ER -